Gastroenterology and Artificial Intelligence: 4th Annual Global Artificial Intelligence Summit

Video Transcription

Video Summary

The video discussion revolves around the application of artificial intelligence (AI) in medical procedures, specifically in cancer prevention and endoscopy. The speakers discuss the challenges of measuring the impact of AI on long-term outcomes like cancer incidence and mortality. They point out that in the short term, AI can provide evidence on intermediate outcomes such as polyp detection. The importance of defining the value of AI based on these intermediate outcomes is emphasized. The discussion also touches upon the liability and responsibility of AI developers, with one speaker suggesting that they should accept liability for the performance of their AI systems. The need for transparency and standardization in AI training data sets is discussed, with the clinicians expressing interest in knowing the populations and diseases included in these data sets. The speakers also consider the implications of AI on malpractice insurance. Overall, the conversation highlights the ongoing discussions and challenges in integrating AI into medical practice.

Asset Subtitle

Michael Abramoff, MD, Nicholas Petrick, PhD, Nayantara Coelho-Prabhu, MD,FASGE,Shyam Thakkar, MD, FASGE

Keywords

artificial intelligence

cancer prevention

endoscopy

polyp detection

liability of AI developers